Post-approval studies (Phase 4)Ended earlyNCT04195958
What this trial is testing
Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma
Who this might be right for
Moderate-to-severe Allergic Asthma
Genentech, Inc. 3